1-181483756-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_001205293.3(CACNA1E):āc.12C>Gā(p.Phe4Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,456,916 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 31)
Exomes š: 0.0000014 ( 0 hom. )
Consequence
CACNA1E
NM_001205293.3 missense
NM_001205293.3 missense
Scores
5
12
2
Clinical Significance
Conservation
PhyloP100: 0.448
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1E. . Gene score misZ 5.8125 (greater than the threshold 3.09). Trascript score misZ 6.7013 (greater than threshold 3.09). GenCC has associacion of gene with developmental and epileptic encephalopathy, developmental and epileptic encephalopathy, 69.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1E | NM_001205293.3 | c.12C>G | p.Phe4Leu | missense_variant | 1/48 | ENST00000367573.7 | NP_001192222.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1E | ENST00000367573.7 | c.12C>G | p.Phe4Leu | missense_variant | 1/48 | 1 | NM_001205293.3 | ENSP00000356545.2 | ||
CACNA1E | ENST00000360108.7 | c.12C>G | p.Phe4Leu | missense_variant | 1/47 | 5 | ENSP00000353222.3 | |||
CACNA1E | ENST00000367570.6 | c.12C>G | p.Phe4Leu | missense_variant | 1/47 | 1 | ENSP00000356542.1 | |||
CACNA1E | ENST00000621791.4 | c.12C>G | p.Phe4Leu | missense_variant | 1/46 | 1 | ENSP00000481619.1 | |||
CACNA1E | ENST00000524607.6 | c.447C>G | p.Phe149Leu | missense_variant | 3/12 | 5 | ENSP00000432038.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1456916Hom.: 0 Cov.: 31 AF XY: 0.00000276 AC XY: 2AN XY: 724578
GnomAD4 exome
AF:
AC:
2
AN:
1456916
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
724578
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with CACNA1E-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 4 of the CACNA1E protein (p.Phe4Leu). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;.;.;.;D;T;.;D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;.;T;.;T;T;T;T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;M;M;.;M;.;M;M;M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
.;D;.;D;D;.;.;.;.
REVEL
Uncertain
Sift
Benign
.;T;.;T;T;.;.;.;.
Sift4G
Uncertain
.;D;D;D;D;D;D;D;D
Polyphen
0.99
.;D;.;.;.;.;D;.;.
Vest4
0.58, 0.59, 0.59, 0.61, 0.52, 0.60, 0.59, 0.60
MutPred
0.36
.;Loss of methylation at R3 (P = 0.0944);Loss of methylation at R3 (P = 0.0944);Loss of methylation at R3 (P = 0.0944);Loss of methylation at R3 (P = 0.0944);Loss of methylation at R3 (P = 0.0944);Loss of methylation at R3 (P = 0.0944);Loss of methylation at R3 (P = 0.0944);Loss of methylation at R3 (P = 0.0944);
MVP
MPC
1.4
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.